XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.2
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS

11. NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS

 

The following tables present reconciliations for the numerators and denominators of basic and diluted net loss per share:

 SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED

  2021   2020   2021   2020 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30,   June 30,   June 30, 
Numerator:  2021   2020   2021   2020 
Net loss  $(3,188)  $(12,677)  $(20,598)  $(25,717)
Less: Gain from change in fair value of warrant liabilities   (107)            
Net loss available to common stockholders  $(3,295)  $(12,677)  $(20,598)  $(25,717)

 

 

   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30,   June 30,   June 30, 
Denominator:  2021   2020   2021   2020 
Basic weighted average number of common shares (1)   80,602,931    38,428,289    78,392,881    35,724,141 
Incremental shares from assumed exercise of warrants   559,325             
Diluted weighted average number of common shares   81,162,256    38,428,289    78,392,881    35,724,141 

 

  (1) In December 2020 and January 2021, the Company sold pre-funded warrants to purchase up to 5,238,043 and 2,420,910 shares of common stock, respectively. The shares of common stock associated with the pre-funded warrants are considered outstanding for the purposes of computing earnings per share prior to exercise because the shares may be issued for little or no consideration, are fully vested, and are exercisable after the original issuance date. The pre-funded warrants sold in December 2020 and January 2021 were exercised during the period and included in the denominator for the period of time the warrants were outstanding.

 

The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share for the periods presented due to their anti-dilutive effect:

 SCHEDULE OF ANTI-DILUTIVE POTENTIAL SHARES OUTSTANDING ACTIVITY

   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30,   June 30,   June 30, 
   2021   2020   2021   2020 
Stock Options   5,940,216    5,110,582    5,940,216    5,110,582 
Restricted stock   5,433,725    4,331,324    5,433,725    4,331,324 
Common stock warrants   18,133,360    10,638,298    19,314,143    10,638,298